SEC ownership of Vicore Pharma Holding AB

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002124403.

Comparable stake leader

HBM Healthcare Investments (Cayman) Ltd.

Disclosed value leader

HBM Healthcare Investments (Cayman) Ltd.

Comparable rows

1/3

Latest evidence

30 Sep 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
1 of 3
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
HBM Healthcare Investments (Cayman) Ltd.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0002124403
Issuer location
Stockholm

Ownership snapshot

Top shareholders of Vicore Pharma Holding AB (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
HBM Healthcare Investment...
Comparable rows
1/3
Latest evidence
30 Sep 2026
13D/G 13F Lead comparable stake: 8% 2 rows are not safely comparable across share classes. 13D/G row: HBM Healthcare Investments (Cayman) Ltd.

Quick read

HBM Healthcare Investments (Cayman) Ltd. leads the comparable SEC ownership view at 8%.

1 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HBM Healthcare Investments (Cayman) Ltd.'s linked filing trail.
Comparable ownership Top 1
HBM Healthcare Investments (Cayma... 8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-3 of 3 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
13D/G
8%
Reported 13D/G · 30 Jun 2026
$245,538,485
22,505,819 shares
$0 30 Jun 2026
FOLKETRYGDFONDET
13F
Company
13F
—
denominator unverified
$9,251,823
972,852 shares
— 30 Sep 2026
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$3,438,296
360,031 shares
— 30 Sep 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 16 Nov 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Vicore Pharma Holding AB

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .